Development of epithelial-mesenchymal transition-related lncRNA signature for predicting survival and immune microenvironment in pancreatic cancerwithexperiment validation-Reference-Cited by-同舟云学术

Development of epithelial-mesenchymal transition-related lncRNA signature for predicting survival and immune microenvironment in pancreatic cancerwithexperiment validation

Published:2021-12-02 Issue:2 Volume:12 Page:10553-10567
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Gao Yong¹,Liu Jinhui²,Cai Baobao¹,Chen Qun¹,Wang Guangfu¹,Lu Zipeng¹,Jiang Kuirong¹,Miao Yi¹³

Affiliation:

1. Pancreas Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing, People’s Republic of China

2. Department of Gynecology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People’s Republic of China

3. Pancreas Center, the Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, People’s Republic of China

Funder

no funding

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2021.2000197

Reference39 articles.

1. Cancer Statistics, 2021

2. Understanding Metastasis in Pancreatic Cancer: A Call for New Clinical Approaches

3. Epithelial-Mesenchymal Transition and Its Regulation Mechanisms in Pancreatic Cancer

4. Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review

5. Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular characterization, clinical value, and cancer–immune interactions of genes related to disulfidptosis and ferroptosis in colorectal cancer;Discover Oncology;2024-05-24

2. Long noncoding RNAs in pancreas cancer: from biomarkers to therapeutic targets;Turkish Journal of Medical Sciences;2023-12-12

3. Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma;Molecular Cancer;2023-07-24

4. Establishment of a novel signature to predict prognosis and immune characteristics of pancreatic cancer based on necroptosis-related long non-coding RNA;Molecular Biology Reports;2023-07-15

5. Construction of a Prognostic Model Based on Cuproptosis-Related lncRNA Signatures in Pancreatic Cancer;Canadian Journal of Gastroenterology and Hepatology;2022-11-11